Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FV8B3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,000
Award facts
- Contract value 100% obligated
- $10,999.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,999.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90 count) on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill this requirement as a critical vendor within the federal medical procurement supply chain. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to efficiently supply a diverse range of pharmaceutical products, including diabetes medications like Jardiance, across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs. This delivery order is part of the company's ongoing support of military and federal healthcare systems through the DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FV8B3?
SPE2DR26FV8B3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FV8B3 worth?
The government has obligated $11,000 on SPE2DR26FV8B3.
Is contract SPE2DR26FV8B3 an order under another contract?
Yes. SPE2DR26FV8B3 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV8B3 competed?
The extent of competition for SPE2DR26FV8B3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award